Plasma and Mucosal Immunoglobulin M, Immunoglobulin A, and Immunoglobulin G Responses to the Vibrio cholerae O1 Protein Immunome in Adults With Cholera in Bangladesh

O-Specific Polysaccharide-Specific Memory B Cell Responses in Young Children, Older Children, and Adults Infected with Vibrio cholerae O1 Ogawa in Bangladesh

(2016) Amena Aktar et al.   Clinical and Vaccine Immunology

Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection WithVibrio choleraeO1 El Tor

(2016) Wilbur H. Chen et al.   CLINICAL INFECTIOUS DISEASES

Single-Cell Analysis of the Plasmablast Response to Vibrio cholerae Demonstrates Expansion of Cross-Reactive Memory B Cells

(2016) Robert C. Kauffman et al.   mBio

A Genome-Wide Screen Reveals that the Vibrio cholerae Phosphoenolpyruvate Phosphotransferase System Modulates Virulence Gene Expression

(2015) Qiyao Wang et al.   INFECTION AND IMMUNITY

The Emergence of 2-Oxoglutarate as a Master Regulator Metabolite

(2015) Luciano F. Huergo et al.   MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS

Dephosphorylated NPr is involved in an envelope stress response of Escherichia coli

(2015) Jaeseop Lee et al.   MICROBIOLOGY-SGM

A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain (OSP:rTTHc) Induces Serum, Memory and Lamina Proprial Responses against OSP and Is Protective in Mice

(2015) Md. Abu Sayeed et al.   PLoS Neglected Tropical Diseases

Immune Responses to O-Specific Polysaccharide and Lipopolysaccharide of Vibrio cholerae O1 Ogawa in Adult Bangladeshi Recipients of an Oral Killed Cholera Vaccine and Comparison to Responses in Patients with Cholera

(2014) Taher Uddin et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

The Bacterial Phosphoenolpyruvate:Carbohydrate Phosphotransferase System: Regulation by Protein Phosphorylation and Phosphorylation-Dependent Protein-Protein Interactions

(2014) Josef Deutscher et al.   MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS

Evaluation in Mice of a Conjugate Vaccine for Cholera Made from Vibrio cholerae O1 (Ogawa) O-Specific Polysaccharide

(2014) Mohammad Murshid Alam et al.   PLoS Neglected Tropical Diseases

Immunoproteomic Analysis of Antibody in Lymphocyte Supernatant in Patients with Typhoid Fever in Bangladesh

(2013) Richelle C. Charles et al.   Clinical and Vaccine Immunology

Immune Responses to the O-Specific Polysaccharide Antigen in Children Who Received a Killed Oral Cholera Vaccine Compared to Responses following Natural Cholera Infection in Bangladesh

(2013) Daniel T. Leung et al.   Clinical and Vaccine Immunology

5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial

(2013) Sujit K Bhattacharya et al.   LANCET INFECTIOUS DISEASES

Enzyme-linked immunospot assays for direct ex vivo measurement of vaccine-induced human humoral immune responses in blood

(2013) Giulietta Saletti et al.   Nature Protocols

The global burden of cholera

(2012) Mohammad Ali et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Comparison of Immune Responses to the O-Specific Polysaccharide and Lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi Adult Patients with Cholera

(2012) Russell A. Johnson et al.   Clinical and Vaccine Immunology

Memory B Cell Responses to Vibrio cholerae O1 Lipopolysaccharide Are Associated with Protection against Infection from Household Contacts of Patients with Cholera in Bangladesh

(2012) Sweta M. Patel et al.   Clinical and Vaccine Immunology

Memory B Cell and Other Immune Responses in Children Receiving Two Doses of an Oral Killed Cholera Vaccine Compared to Responses following Natural Cholera Infection in Bangladesh

(2012) Daniel T. Leung et al.   Clinical and Vaccine Immunology

Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age

(2011) Amit Saha et al.   VACCINE

The Cholera Pandemic, Still with Us after Half a Century: Time to Rethink

(2011) Edward T. Ryan   PLoS Neglected Tropical Diseases

Efficacy of a Low-Cost, Inactivated Whole-Cell Oral Cholera Vaccine: Results from 3 Years of Follow-Up of a Randomized, Controlled Trial

(2011) Dipika Sur et al.   PLoS Neglected Tropical Diseases

Reactogenicity of live-attenuated Vibrio cholerae vaccines is dependent on flagellins

(2010) H. Rui et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Antigen-Specific Memory B-Cell Responses to Vibrio cholerae O1 Infection in Bangladesh

(2009) A. M. Harris et al.   INFECTION AND IMMUNITY

Memory T-Cell Responses to Vibrio cholerae O1 Infection

(2009) A. A. Weil et al.   INFECTION AND IMMUNITY

An Alternative Polyamine Biosynthetic Pathway Is Widespread in Bacteria and Essential for Biofilm Formation inVibrio cholerae

(2009) Jeongmi Lee et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: A randomized, placebo-controlled trial

(2009) Suman Kanungo et al.   VACCINE

Requirements for the phosphorylation of theEscherichia coliEIIANtrproteinin vivo

(2008) Björn Zimmer et al.   FEMS MICROBIOLOGY LETTERS

Decreased Potency of the Vibrio cholerae Sheathed Flagellum To Trigger Host Innate Immunity

(2008) S. S. Yoon et al.   INFECTION AND IMMUNITY

Cholera Toxin–Specific Memory B Cell Responses Are Induced in Patients with Dehydrating Diarrhea Caused byVibrio choleraeO1

(2008) Channa R. Jayasekera et al.   JOURNAL OF INFECTIOUS DISEASES

Susceptibility to Vibrio cholerae Infection in a Cohort of Household Contacts of Patients with Cholera in Bangladesh

(2008) Jason B. Harris et al.   PLoS Neglected Tropical Diseases

Vibrio cholerae cytolysin is essential for high enterotoxicity and apoptosis induction produced by a cholera toxin gene-negative V. cholerae non-O1, non-O139 strain

(2007) Hector Alex Saka et al.   MICROBIAL PATHOGENESIS